secwatch.observer — SEC 8-K summary
======================================

Issuer:     Imunon, Inc. (IMNN)
CIK:        0000749647
Form:       8-K
Filed at:   2024-09-03T23:59:59+00:00
Accession:  0001493152-24-034716
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Imunon resumes at-the-market stock offering after previous suspension
---------------------------------------------------------------------

- On Sept 3, 2024, Imunon filed a new prospectus supplement to resume sales under the existing ATM agreement.
- The ATM program had been suspended on July 30, 2024 via termination of the sales prospectus.
- The ATM Agreement (May 2022, amended May 2024) with H.C. Wainwright remains in force.
- Legal opinion on share validity from Covington & Burling filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/749647/000149315224034716/0001493152-24-034716-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/749647/000149315224034716/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-034716

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer